rs2304795 — PLIN1

Synonymous exon 8 variant in perilipin 1 that tags a haplotype associated with fat mobilization efficiency and sex-specific obesity risk

See your personal result for PLIN1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Perilipin Gatekeeper: How rs2304795 Shapes Fat Mobilization

Perilipin 1 (PLIN1) is the most abundant protein coating lipid droplets11 most abundant protein coating lipid droplets
Lipid droplets are the cellular fat-storage organelles inside adipocytes, each wrapped in a protein shell that controls access to the stored triglycerides in fat cells. Think of it as a bouncer at the door to your fat stores — in the unfed state, perilipin keeps lipases locked out, preventing uncontrolled fat breakdown. When energy is needed and hormones signal via PKA phosphorylation22 PKA phosphorylation
Protein kinase A phosphorylates perilipin at multiple serine residues, triggering a conformational change that exposes stored triglycerides to lipases, perilipin opens the door for hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL)33 hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL)
The two key enzymes that sequentially break down stored triglycerides into free fatty acids during fat mobilization to break down stored fat. Common variants at the PLIN1 locus subtly alter this gatekeeping function, influencing how readily adipose tissue releases fat under caloric stress.

rs2304795 (13041A>G) is a synonymous variant in exon 8 — it does not change the amino acid sequence at position 371 (proline remains proline). Nevertheless, it has been consistently implicated in obesity risk and fat mobilization across multiple populations, most likely because it serves as a marker for a linked functional variant44 marker for a linked functional variant
Synonymous variants can tag haplotypes carrying nearby causal variants, or can themselves affect mRNA structure, splicing efficiency, or translational rate elsewhere in the PLIN1 haplotype block.

The Mechanism

The G allele tags a haplotype that appears to confer stronger perilipin-mediated protection of lipid droplets. Under this model, fat cells with G-allele haplotypes are more resistant to lipolytic signals — stored triglycerides remain sequestered for longer during energy deficit. This has two opposing consequences: in the context of chronic positive energy balance, stronger fat retention elevates obesity risk; in conditions of extreme catabolism (severe illness, cancer treatment), it offers partial protection against uncontrolled fat mass loss.

The molecular basis likely involves expression-level changes in PLIN1 isoforms or altered mRNA structure affecting translation efficiency, though direct functional characterization of this specific synonymous change has not been published. The strong sex-specificity of associations — effects are predominantly observed in women — is consistent with perilipin's known interactions with estrogen-regulated lipolytic signaling55 estrogen-regulated lipolytic signaling
Estrogens modulate beta-adrenergic receptor density and PKA responsiveness in adipose tissue, creating sex-specific sensitivity to perilipin variants.

The Evidence

The foundational study by Qi et al. 200466 Qi et al. 2004
n=734 white US adults (373 men, 361 women); first systematic analysis of PLIN1 haplotype and obesity identified rs2304795 and rs1052700 as obesity-associated, with minor G alleles linked to increased obesity risk in women. Associations with percentage body fat and waist circumference were significant in women but not men.

In an endurance exercise intervention77 endurance exercise intervention
6-month supervised training in 101 older Caucasians (mean age 63), the major AA haplotype (carriers of the common A allele at both rs2304795 and rs1052700) was associated with lower baseline BMI, lower body fat, and lower intra-abdominal fat compared to non-carriers before and after training. The PLIN haplotype explained approximately 2.5% of variance in body composition phenotypes.

The most striking data on rs2304795 comes from an oncology cohort88 oncology cohort
80 head and neck cancer patients (60 men, 20 women) undergoing radiotherapy; Polish population. AA genotype men lost 37.01% of their fat mass during treatment versus 12.82% in GA carriers and only 0.31% in GG carriers (p = 0.035). In multivariate analysis, the AA genotype carried an OR of 13.78 for ≥10% fat mass loss (p = 0.032). This extreme effect — a genotype explaining a 100-fold difference in fat loss magnitude — is unusual in genetics and likely reflects acute metabolic stress amplifying a normally subtle regulatory difference. Nonetheless, it illustrates the functional range of this variant: the G allele strongly protects fat from mobilization even under duress.

Evidence for dietary weight loss interventions is more modest. In a 12-week caloric restriction study99 12-week caloric restriction study
Energy restriction to -300 kcal/day; 4.6% mean weight loss, rs2304795 haplotype influenced serum free fatty acid levels and abdominal fat responses. An 8-week energy restriction study1010 8-week energy restriction study
Obese Spanish women, -500 kcal/day found no interaction between the 13041A>G variant and diet-induced changes in body fat or energy metabolism independently, suggesting its effects may require haplotype context (i.e., co-occurring with rs1052700).

Overall evidence level is moderate: consistent replication across populations for obesity risk associations, a clear biological framework, but no randomized controlled trials and no clinical guidelines. Effect sizes are modest for obesity risk but large and highly specific in metabolic stress conditions.

Interactions

rs2304795 is most commonly studied as part of a haplotype with rs10527001111 rs1052700
The 14995A>T variant in the PLIN1 3′ region, in moderate LD with rs2304795 and with its own independent association with weight loss response (14995A>T). The combined AA haplotype at both positions defines a "low-fat-retention" phenotype associated with lower baseline body fat and better responses to exercise. Individuals carrying the AG haplotype (AA at rs2304795, TT at rs1052700) occupy an intermediate position. The rs894160 and rs2289487 pair1212 rs894160 and rs2289487 pair
Strongly linked to each other in white populations; associated with protective effects against obesity in Spanish women but not US women, illustrating population-dependent LD patterns represents a second, partially independent PLIN1 haplotype with its own obesity associations, underscoring the complexity of variation across this locus.

Nutrient Interactions

dietary fat altered_metabolism
protein increased_need

Genotype Interpretations

What each possible genotype means for this variant.

AA High Fat Mobility Normal

Common genotype associated with normal to high lipolytic sensitivity in adipose tissue

The AA genotype represents the ancestral haplotype at the PLIN1 locus. Cross-population data from gnomAD show an A allele frequency of approximately 62%, making AA the most common single genotype. In exercise intervention studies, AA haplotype carriers showed significantly lower total body fat and intra-abdominal fat both before and after a 6-month endurance training program compared to G allele carriers, suggesting more efficient baseline fat mobilization. The most dramatic illustration of this genotype's higher lipolytic sensitivity came from an oncology study in which AA men undergoing radiotherapy lost 37% of their fat mass compared to 12% in AG carriers and virtually none in GG carriers — an extreme amplification of the same underlying biological difference under catabolic stress.

This does not mean AA individuals are immune to obesity — lifestyle, diet, and other genetic factors dominate adiposity outcomes. But when placed in caloric deficit, AA carriers tend to mobilize fat stores more readily than G allele carriers.

AG Moderate Fat Retention Intermediate

One G allele moderately increases adipose resistance to lipolysis, with sex-specific obesity risk in women

Heterozygote AG carriers occupy an intermediate position in the PLIN1 lipolysis spectrum. In the head and neck cancer radiotherapy study, AG men lost 12.82% of their fat mass during treatment — intermediate between AA carriers (37%) and GG carriers (0.3%).

The sex specificity of PLIN1 effects is consistent with the known interaction between estrogens and adipose lipolysis. Women have higher perilipin expression in certain fat depots and different beta-adrenergic receptor densities compared to men, creating a hormonal context where PLIN1 genetic variation has measurable phenotypic consequences. The AG genotype in women may particularly affect lower-body (gluteofemoral) fat stores, which are more perilipin-dense than abdominal fat.

GG High Fat Retention High Risk

Two G alleles confer the strongest perilipin-mediated protection of fat stores, with higher obesity risk and reduced fat mobilization during caloric deficit

The GG genotype represents the high-fat-retention end of the PLIN1 spectrum. In the most striking published dataset — a study of cancer patients undergoing radiotherapy — GG men lost only 0.31% of their fat mass during treatment compared to 12.82% in AG carriers and 37% in AA carriers, yielding an OR of 13.78 for ≥10% fat mass loss associated with the AA genotype (reference for GG). While this extreme catabolic context amplifies the effect, it illustrates a fundamental biological difference in lipolytic sensitivity.

In population studies, the GG genotype (as part of the G-allele haplotype) is associated with increased obesity risk in women, higher body fat percentage, and greater waist circumference. The exercise intervention study found that G allele carriers maintained higher BMI and body fat throughout a 6-month endurance training program compared to AA carriers.

Mechanistically, the GG haplotype likely keeps more perilipin molecules in the unphosphorylated, lipid-droplet-protective state, requiring stronger or more sustained hormonal signals to initiate effective lipolysis.